ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of the Geriatric Activation Program Pellenberg (GAPP) on the Geriatric Rehabilitation Ward

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03109483
Recruitment Status : Recruiting
First Posted : April 12, 2017
Last Update Posted : July 18, 2018
Sponsor:
Collaborator:
Universitaire Ziekenhuizen Leuven
Information provided by (Responsible Party):
Margreet van Dijk, KU Leuven

Brief Summary:

The aim of this study is to investigate the effectiveness of our developed week-treatment program GAPP, on strength, balance, speed, functionality and cognition, with the main goal to achieve a better independence for activities of daily living (ADL).

Each day of the week an exercise program of 45 minutes is given assigned to a specific aspect of the rehabilitation; strength, balance, speed, functional training and one day is for testing or group therapy.

Participants will be followed for four weeks, with testing on day one, after two weeks and at the last day of the four-week program.


Condition or disease Intervention/treatment Phase
Stroke Hip Fractures Abdominal Injury Chronic Obstructive Pulmonary Disease Other: Geriatric Activation Program Pellenberg Not Applicable

Detailed Description:

The aim of this study is to investigate the effectiveness of our developed week-treatment program GAPP (Geriatric Activation Program Pellenberg), on strength, balance, speed, functionality and cognition, with the main goal to achieve a better independence for ADL.

Each day of the week an exercise program of 45 minutes is given assigned to a specific aspect of the rehabilitation.

Monday: speed and coordination, including as many repetitions as possible in one minute for: quick arm movements in standing, quick trunk movements in sitting, quick weight transfers in standing, stepping.

Tuesday: functional training, including walking stairs, transfers, sitting to lying and reverse, moving objects in the room, functional fit-o-meter.

Wednesday: balance, including maximum weight transfers in all directions, exercises with reduced base of support, reaching.

Thursday: strength, including sit to stand with a weight belt, lifting a weight bimanual of the table, walking with ankle weights, arm extension with therapy bands.

Friday: testing or group activity. One week the following test will be taken: Berg Balance Scale, 10m walking test, Digit Symbol Substitution Test, knee extension and elbow extension strength with the microfet2, Basic-ADL and Geriatric Depression Scale.

The other week there will be a group session, this could be in sitting (like moving on music) or standing (like petanque).

Walking will be practiced every day of the week and individual needs (like specific hand rehabilitation or pain problems) will be addressed besides the program when needed.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Intervention Model: Single Group Assignment
Intervention Model Description: explorative study
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effectiveness of the Geriatric Activation Program Pellenberg (GAPP) on the Geriatric Rehabilitation Ward
Actual Study Start Date : March 17, 2017
Estimated Primary Completion Date : March 2019
Estimated Study Completion Date : May 30, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation

Arm Intervention/treatment
Geriatric Activation Program Pellenberg
intensive multicomponent physical therapy week program
Other: Geriatric Activation Program Pellenberg
intensive multicomponent physical therapy week program




Primary Outcome Measures :
  1. Independence for activities of daily living [ Time Frame: four weeks ]
    Independence for ADL measured with the Basic-ADL

  2. Functional Balance [ Time Frame: four weeks ]
    Functional balance measured with the Berg Balance Scale


Secondary Outcome Measures :
  1. Walking speed [ Time Frame: four weeks ]
    Walking speed measured with the 10m walking test

  2. Strength of arm Extension [ Time Frame: four weeks ]
    Strength of arm extension, measured with the microFET2 hand held dynamometer. The mean peak force in Newton of three trail will be used.

  3. Strength of knee extension [ Time Frame: four weeks ]
    Strength of Knee extension, measured with the microFET2 hand held dynamometer. The mean peak force in Newton of three trail will be used.

  4. Cognitive function [ Time Frame: four weeks ]
    The Digit Symbol Substitution Test will be used to measure response speed, sustained attention

  5. General state of mind [ Time Frame: four weeks ]
    General state of mind measured with the Geriatric Depression Scale 15



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   70 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • admitted to the geriatric rehabilitation ward of UZ Leuven, campus Pellenberg
  • the ability to walk 10m with help of a person or walking aid
  • an expected stay of at least four weeks
  • a signed informed consent

Exclusion Criteria:

  • medically instable
  • not able to understand the questions and tasks of the program or testing

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03109483


Locations
Belgium
Universitaire Ziekenhuizen Leuven, campus Pellenberg Recruiting
Pellenberg, Belgium, 3212
Contact: Margreet van Dijk, Msc    0032 16332894    margaretha.vandijk@uzleuven.be   
Contact: Geert Verheyden, PhD       geert.verheyden@kuleuven.be   
Sponsors and Collaborators
KU Leuven
Universitaire Ziekenhuizen Leuven

Responsible Party: Margreet van Dijk, Physical Therapist, KU Leuven
ClinicalTrials.gov Identifier: NCT03109483     History of Changes
Other Study ID Numbers: S59948 / B322201731432
First Posted: April 12, 2017    Key Record Dates
Last Update Posted: July 18, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Margreet van Dijk, KU Leuven:
geriatric patients
elderly
multicomponent physical therapy

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Hip Fractures
Abdominal Injuries
Respiratory Tract Diseases
Femoral Fractures
Fractures, Bone
Wounds and Injuries
Hip Injuries
Leg Injuries